Daniel S. Chen

Genentech ORCID: 0000-0001-5085-3579

5

h-index

5

Publications

17,212

Citations

Publications

5 shown

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst , Jean‐Charles Soria , Marcin Kowanetz +19 more

2014 Nature 5125 citations

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Thomas Powles , Joseph P. Eder , Gregg Fine +12 more

2014 Nature 2392 citations

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan , Shannon J. Turley , Dorothee Nickles +39 more

2018 Nature 5078 citations

VEGF in Signaling and Disease: Beyond Discovery and Development

Rajendra S. Apte , Daniel S. Chen , Napoleone Ferrara

2019 Cell 2499 citations

Top 10 Challenges in Cancer Immunotherapy

Priti S. Hegde , Daniel S. Chen

2020 Immunity 2118 citations

Frequent Co-Authors

Roy S. Herbst

Yale Cancer Center

Jean‐Charles Soria

Institut Gustave Roussy

Marcin Kowanetz

Gregg Fine

Omid Hamid

Angeles Clinic and Research Institute

Michael S. Gordon

Pinnacle Oncology Hematology

Researcher Info

h-index: 5
Publications: 5
Citations: 17,212
Institution: Genentech

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5085-3579

Impact Metrics

h-index 5

h-index: Number of publications with at least h citations each.